Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Umut Elboğa"'
Autor:
Ertan Şahin, Umut Elboğa
Publikováno v:
Haseki Tıp Bülteni, Vol 56, Iss 1, Pp 22-27 (2018)
Aim: Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) are used as inflammatory markers in several diseases. However, there are little data regarding the diagnostic ability of NLR and PLR in Helicobacter pylori. We aimed to assess
Externí odkaz:
https://doaj.org/article/80740b1a66394afb8a432ae0f2af1bd5
Autor:
Umut Elboğa, Ebuzer Kalender, Ertan Şahin, Y. Zeki Çelen, Mustafa Yılmaz, Mustafa Başıbüyük, Yavuz Pehlivan
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 2, Iss 2, Pp 86-89 (2014)
Heterotopic ossification is a process characterized by the formation of genuine new bone in soft tissues especially between muscle and joint capsule and frequently encountered after spinal cord and traumatic brain injury. A 35-year-old woman who had
Externí odkaz:
https://doaj.org/article/29b1e24c66de41b8b182814414d90534
Autor:
Muhammet Sancaktar, Şengül Kocamer Şahin, Bahadır Demir, Umut Elboğa, Gülçin Elboğa, Abdurrahman Altındağ
Publikováno v:
Journal of Neural Transmission. 130:145-152
Autor:
Gamze Kaya Çapa, Cuneyt Turkmen, İlknur Ak Sivrikoz, Nalan Alan Selçuk, Umut Elboğa, Gülin Uçmak, Emre Demirci, Levent Kabasakal
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 3, Pp 385-396 (2020)
Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and PSMA-directed radioligand therapy (RLT) with Lutetium-177 (Lu-177) PSMA is promising systemic modality, which involves the delivery of targeted radiation therapy in t
Autor:
Levent Kabasakal, Nalan Alan Selçuk, Gülin Uçmak, Cuneyt Turkmen, Emre Demirci, Umut Elboğa, İlknur Ak Sivrikoz
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 3, Pp 416-422 (2020)
Yttrium-90 microsphere therapy, which has become more common in recent years, offers an effective and safe radionuclide treatment option in the treatment of primary and metastatic liver tumors. The success of the treatment is directly related to the
Autor:
Nalan Alan Selçuk, Umut Elboğa
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 3, Pp 423-435 (2020)
Skeletal system is the most common metastasis site in patients with advanced cancer. Pain is an important health problem in patients with bone metastasis. Bone seeking radionuclides to treat bone pain due to bone metastasis in patients with advanced
Autor:
Umut Elboğa, Nalan Alan Selçuk, İlknur Ak Sivrikoz, Gülin Uçmak, Emre Demirci, Cuneyt Turkmen, Levent Kabasakal
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 3, Pp 406-415 (2020)
Peptide receptor radionuclide therapy (PRRT) have been successfully used for the past 20 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptors. Both prospective and retrospective studies indicate that pa
Autor:
Nalan Alan Selçuk, Umut Elboğa, Cuneyt Turkmen, Gülin Uçmak, İlknur Ak Sivrikoz, Levent Kabasakal, Emre Demirci
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 3, Pp 397-405 (2020)
Neuroendocrine tumors (NETs) are one of the rare cancers that have been increasing in recent years. The importance of Ga-68 DOTA-Conjugated Peptides Receptor imaging has been reported in many retrospective and prospective studies in the diagnosis and
Autor:
Umut Elboğa
Publikováno v:
Nükleer Tıp Seminerleri, Vol 6, Iss 1, Pp 28-38 (2020)
Skeletal system is the most common metastasis site in patients with advanced cancer. Pain is an important health problem in patients with bone metastasis. Bone seeking radionuclides to treat bone pain due to bone metastasis in patients with advanced
Publikováno v:
Turkiye Klinikleri Journal of Sports Sciences. 12:120-128